Richard-Carpentier, G. “Venetoclax-Based Lower-Intensity Regimens for Acute Myeloid Leukemia: Clinical Pearls for a New Standard of Care”. Canadian Hematology Today, vol. 2, no. 1, Mar. 2023, pp. 28–33, doi:10.58931/cht.2023.2125.